BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1170 related articles for article (PubMed ID: 16489319)

  • 1. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of body mass index versus waist circumference with the metabolic changes that increase the risk of cardiovascular disease in insulin-resistant individuals.
    Farin HM; Abbasi F; Reaven GM
    Am J Cardiol; 2006 Oct; 98(8):1053-6. PubMed ID: 17027570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward an improved diagnosis of the metabolic syndrome other clues to the presence of insulin resistance.
    Cohn GS; Kittleson MM; Blumenthal RS
    Am J Hypertens; 2005 Aug; 18(8):1099-103. PubMed ID: 16109324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile: the price paid to maintain glucose homeostasis in insulin-resistant individuals.
    Reaven GM
    Endocrinol Metab Clin North Am; 2005 Mar; 34(1):49-62. PubMed ID: 15752921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostasis alterations in metabolic syndrome (review).
    Palomo I; Alarcón M; Moore-Carrasco R; Argilés JM
    Int J Mol Med; 2006 Nov; 18(5):969-74. PubMed ID: 17016629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo synthesis of diacylglycerol in endothelium may mediate the association between PAI-1 and the insulin resistance syndrome.
    McCarty MF
    Med Hypotheses; 2005; 64(2):388-93. PubMed ID: 15607575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance/compensatory hyperinsulinemia predict carotid intimal medial thickness in patients with essential hypertension.
    Zavaroni I; Ardigò D; Zuccarelli A; Pacetti E; Piatti PM; Monti L; Valtueña S; Massironi P; Rossi PC; Reaven GM
    Nutr Metab Cardiovasc Dis; 2006 Jan; 16(1):22-7. PubMed ID: 16399488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.
    Kendall DM; Harmel AP
    Am J Manag Care; 2002 Dec; 8(20 Suppl):S635-53; quiz S654-7. PubMed ID: 12510788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disorders of lipid metabolism in insulin resistance].
    Müller-Wieland D; Krone W
    Herz; 1995 Feb; 20(1):33-46. PubMed ID: 7713475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors?
    Lind L; Lithell H; Pollare T
    J Hypertens Suppl; 1993 Jun; 11(4):S11-6. PubMed ID: 8377030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism].
    Krone W; Müller-Wieland D; Wirth H
    Fortschr Med; 1992 Dec; 110(34):645-8. PubMed ID: 1483617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid and lipoprotein dysregulation in insulin resistant states.
    Avramoglu RK; Basciano H; Adeli K
    Clin Chim Acta; 2006 Jun; 368(1-2):1-19. PubMed ID: 16480697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperinsulinemia and cardiovascular risk.
    Arrants J
    Heart Lung; 1994; 23(2):118-22; 123-4. PubMed ID: 8206768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome.
    Reaven P
    J Insur Med; 2004; 36(2):132-42. PubMed ID: 15301226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperinsulinism/insulin resistance: cause, effect or marker of essential arterial hypertension?].
    Greco D; Sinagra D
    G Ital Cardiol; 1995 Feb; 25(2):207-16. PubMed ID: 7642026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperinsulinemia and cardiovascular risk].
    Brunelli C; Spallarossa P; Cordera R; Caponnetto S
    Cardiologia; 1994 Dec; 39(12 Suppl 1):163-8. PubMed ID: 7634261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome and cardiovascular disease.
    Bonora E
    Ann Med; 2006; 38(1):64-80. PubMed ID: 16448990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.